Company Search:
Advanced Search
Sponsored Links
Botanix Pharmaceuticals Ltd Company Snapshot
Botanix Pharmaceuticals Ltd operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Botanix Pharmaceuticals Ltd with three other companies in this sector in AUSTRALIA : Vectus Biosystems Ltd (2021 sales of 81,590.00 Australian Dollars [US$59,467.69 ] ), Cynata Therapeutics Ltd (79,705.00 Australian Dollars [US$58,093.79 ] of which 100% was Development and commercialisation), and Opthea Ltd (68,613.00 Australian Dollars [US$50,009.27 ] of which 100% was Medical Technology and Healthcare Indust).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Botanix Pharmaceuticals Ltd
  Stock Performance Chart for Botanix Pharmaceuticals Ltd
  Stock Data: Recent Stock Performance:
  Current Price (9/17/2021): .07
(Figures in Australian Dollars)
1 Week -2.7%   13 Weeks -6.5%  
4 Weeks 4.3%   52 Weeks 26.3%  
Botanix Pharmaceuticals Ltd Key Data:
  Ticker: BOT Country: Australia
  Exchanges: ASX Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2021 Sales 103,788
(Year Ending Jan 2022).
Employees: 1
  Currency: Australian Dollars Market Cap: 70,066,229
  Fiscal Yr Ends: June Shares Outstanding: 973,142,074
  Share Type: Ordinary Closely Held Shares: 244,468,651
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.